Trojan drugs: counterfeit and mislabeled pharmaceuticals in the legitimate market.

نویسنده

  • Donald deKieffer
چکیده

Over the past five years, there have been over 140 reported incidents of counterfeit and mislabeled drugs being sold by legitimate pharmacies in the United States. Thousands of patients have consumed these medications, sometimes with dire consequences. The extent of counterfeits in the legitimate market, however, is unknown. It is certain that the detected incidents of fakes are a fraction of the total number of incidents. How did these drugs wind up in the bloodstreams of unsuspecting patients? Despite elaborate safety precautions, strict regulations and battalions of enforcement personnel, the stream of phony pharmaceuticals continues unabated. This article will consider the practical and legal dimensions of trade in Trojan drugs. This paper will not consider the two major sources of counterfeit medications in the U.S. – direct importation and internet pharmacies. These routes are the subject of numerous scholarly articles and the field is so vast that they deserve separate

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The dangers of sexual enhancement supplements and counterfeit drugs to “treat” erectile dysfunction

Counterfeit phosphodiesterase-5 inhibitors (PDE-5i) are an increasing problem. Already in widespread use, the market for PDE-5i is steadily growing as the population ages. Counterfeiters are taking advantage of this growing market by developing illicit and counterfeit PDE-5i products. Many factors are contributing to the rapid growth of the illicit market, such as the low risk of prosecution, p...

متن کامل

Some Aspects of the Problem of Adulterated Herbal Medicines by the Illegal Addition of Active Pharmaceutical Ingredients

Counterfeit drugs have become a widespread threat to the publics’ health [1]. According to the World Health Organization (WHO) definition, a counterfeit drug is “a medicine which is deliberately and fraudulently mislabeled with respect to identity and/or source. Counterfeiting can apply to both branded and generic products and counterfeit products may include products with the correct ingredien...

متن کامل

Caveat oncologist: clinical findings and consequences of distributing counterfeit erythropoietin in the United States.

PURPOSE Counterfeit pharmaceuticals pose risks domestically. Because of their cost, cancer pharmaceuticals are vulnerable. We review findings from a domestic counterfeiting episode involving erythropoietin and outline anticounterfeiting recommendations for policy makers, patients, and health care professionals. MATERIALS AND METHODS Information was obtained on patients who received counterfei...

متن کامل

Public Health Measures to Fight Counterfeit Medicine Market

DEAR EDITOR, World Health Organization defines a counterfeit medicine as the one which is deliberately and fraudulently mislabeled with respect to identity and/ or source. It incorporates both branded and generic products and even includes products with correct/ wrong/insufficient/no active ingredients, or fake packaging. However, the European Union has proposed falsified medicines as a more ap...

متن کامل

Iranian Pharmacists’ Knowledge, Attitude and Practice Regarding Counterfeit Drugs

Background Awareness of pharmacists about counterfeit drugs is necessary for health improvement in community. The purpose of the present study is to assess the knowledge and measure the professional attitude and practice of Iranian pharmacist about counterfeit drugs. In August 2008, a knowledge, attitude and practice (KAP) study was performed in a national sample of 794 pharmacists who particip...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • American journal of law & medicine

دوره 32 2-3  شماره 

صفحات  -

تاریخ انتشار 2006